United States: Digital Health Pulse: Regulatory And Transactional Developments

In this recently released podcast, Ropes & Gray life science partners Gregory Levine (Washington, D.C.), Albert Cacozza (Washington, D.C.) and Michael Beauvais (Boston) cover the latest changes in digital health regulation, investment and transactions, providing insights on disruptive forces, the current and future regulatory landscape, and current and expected investments in the market.

Mr. Levine:  I'm Greg Levine, a partner in the life sciences practices at Ropes & Gray. I'm here today with my partners Al Cacozza and Mike Beauvais to discuss the rapidly-changing digital health landscape. We have seen significant investments in digital health, but also significant uncertainty about the regulation of these products. Al, let's start with the regulatory issues. What are some of the latest developments there and how are they affecting companies in this space?

Mr. Cacozza:  Well, Greg, there have been a number of developments on the regulatory front. The FDA, for example, has issued a series of guidelines, most recently the general wellness guideline, which has clarified the regulatory authority, in terms of whether or not products in this space are considered medical devices or not. And the FDA, which had been subject to significant criticism by the industry, has really, I think, gone out of its way to try and be as clear as possible that they are going to focus their attention on those products that are classic medical devices that raise potential safety risks to the patient. And so, for example, in the general wellness guidance, they've indicated they are not intending to regulate as devices any product, including software or wearables, that focuses on wellness issues or that even identifies specific chronic diseases, provided that those products are focusing on the lifestyle aspects of those diseases. For example, a product that monitors your caloric intake to help a diabetic manage a diabetes condition or that focuses on your sleep patterns in terms of documenting those patterns that help if someone is suffering from depression. So I think that the FDA has helped give a roadmap to companies in this area, in terms of whether they will be regulated or not. 

Mr. Levine:  Turning toward the future, what do you see on the horizon for digital health regulation?

Mr. Cacozza:  On the flip side, while the FDA has been cutting back on its regulatory authority in this industry, other agencies, particularly the FTC, have stepped up to say that they are going to enforce their classic unfair trade practices and privacy and security authority over the companies in this space. I think you'll also see that state attorneys general in some states where they're passing new laws are taking a more active role in looking at products that are coming out of this industry. So what you'll see in the future is perhaps a shift away from classic FDA regulation, and more toward general business regulation and privacy and data security regulation by both the FTC and the state regulators.

Mr. Levine:  Thanks, Al. A lot happening, obviously, on the regulatory side. Now let's turn to the transactional side of things. Mike, why don't you tell us about what you're seeing there? 

Mr. Beauvais:  Thanks, Greg. Well, let's start with the data. So for 2015 we had over 180 M&A transactions in the digital health space. We also had $4.5 billion invested in digital health companies. We had five IPOs, most notably FitBit and Teladoc. And for 2016, so far it's going to even surpass 2015. We have $3.9 billion in digital health funding. What's most interesting to me is that over 65% of the deal volume, in terms of investments, was focused in the early stages, so we're talking Series A rounds. Further, kind of slicing that data, you had patient and consumer experience companies being number one, then you had wellness, personalized health and big data analytics falling behind those as well. So that's kind of where the dollars are going on the transactional side. In terms of the disruptive forces at play here, I think there are a few key points. One is rapid market changes, so you have this newfound ability to collect, process and apply learning to all these different data streams, you have the new technology and tools for monitoring lifestyle and health generally, and then you have intensive community interest. So that's kind of on the market change side of the fence. On the legal changes side we have, as Al had mentioned, significant regulatory focus, both at the federal and state level, you have the demise of strong patent protection, as it relates to some of these technologies. And then you also have the Affordable Care Act, and the different payers looking at using bundled payments and other methodologies to see whether or not there's any true data proposition for use of these technologies.

Mr. Levine:  So you've told us about the current market, and a bit about some disruptive forces. What do you see coming down the pike in the future? 

Mr. Beauvais:  So for 2016, I continue to think it will rival if not surpass 2015 in terms of investment in this space. I think you're going to see a lot of the early-stage companies fail, but the ones that are able to address at least one of the propositions that we've been talking about in this podcast, facing companies and consumerables, they will be able to demonstrate that they do have either market acceptance of the products, that they've been able to either surpass or get around any legal or regulatory hurdles as a way to differentiate their products. I think you're going to see data privacy and security being also an important tenet of these products, so to the extent that a product is able to demonstrate that they are either HIPAA-compliant, to the extent that they use protected health information, or that they're able to operate independent of those regulations is critical, and then finally the value proposition. Showing that the technology can either improve patient outcomes or save commercial dollars, as these technologies are applied I think will certainly be of interest to the investor community.

Mr. Levine:  Thanks so much, Mike and Al, to you, for your insights, and thanks for listening. Please visit the digital health page at www.ropesgray.com for additional insights into digital health developments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.